Return to work after breast cancer treatments: Rebuilding everything despite feeling "in-between".


Journal

European journal of oncology nursing : the official journal of European Oncology Nursing Society
ISSN: 1532-2122
Titre abrégé: Eur J Oncol Nurs
Pays: Scotland
ID NLM: 100885136

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 27 12 2018
revised: 02 06 2019
accepted: 10 06 2019
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 21 11 2019
Statut: ppublish

Résumé

The aim of this longitudinal qualitative study is to describe the return-to-work (RTW) journey from the end of breast cancer (BC) treatments to RTW. Nine BC survivors were recruited in the province of Quebec (Canada). The participants, francophones between 30 and 60 years old, had received chemotherapy treatments and planned to RTW in the next six months. The interviews were performed at the end of cancer treatments (n = 9), one month before RTW (n = 9), and after RTW (n = 5). A content analysis was performed based on an iterative process. The first six months after the end of treatment was identified as an "in-between" period, during which participants questioned their ability to return to normal life due to the impact of side effects and a sense of withdrawal from health-care services. A three-stage journey similar to a rite of passage process (Van Gennep, 1969) was observed. 1) BC survivors became aware of feeling on the fringes of the workplace as they awaited RTW. 2) During that waiting period, BC survivors were rebuilding a "normal routine" and taking actions on their own in order to re-enter their workplace. 3) After RTW, they needed to make adjustments to maintain a work routine. Support for BC survivors resuming their active lives needs to be optimized. BC survivors require support on side effect management, RTW decision-making, and resources for resuming daily activities. Nurses must be aware of the "in-between" period so that they can help BC survivors rebuild their confidence during this rite of passage process.

Identifiants

pubmed: 31358250
pii: S1462-3889(19)30072-9
doi: 10.1016/j.ejon.2019.06.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-172

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Karine Bilodeau (K)

Faculty of Nursing, Université de Montréal, PO Box 6128, Station Centre-ville, H3C 3J7, QC, Canada. Electronic address: Karine.bilodeau.2@umontreal.ca.

Dominique Tremblay (D)

Faculty of Medicine and Health Sciences, Université de Sherbrooke, 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada; Hôpital Charles-LeMoyne Research Center, 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.

Marie-José Durand (MJ)

Faculty of Medicine and Health Sciences, Université de Sherbrooke, 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada; Centre for Action in Work Disability Prevention and Rehabilitation, Université de Sherbrooke, 150 Place Charles-Le Moyne, Longueuil, QC, J4K 0A8, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH